{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:42:59Z","timestamp":1793324579304,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bpobgyn.2020.02.008","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T11:36:21Z","timestamp":1583148981000},"page":"98-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":191,"special_numbering":"C","title":["Primary HPV screening for cervical cancer"],"prefix":"10.1016","volume":"65","author":[{"given":"Neerja","family":"Bhatla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bpobgyn.2020.02.008_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"Ca - Cancer J Clin"},{"issue":"7188","key":"10.1016\/j.bpobgyn.2020.02.008_bib2","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/bmj.318.7188.904","article-title":"Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics","volume":"318","author":"Quinn","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib3","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ijc.21955","article-title":"Overview of the European and North American studies on HPV testing in primary cervical cancer screening","volume":"119","author":"Cuzick","year":"2006","journal-title":"Int J Canc"},{"issue":"4","key":"10.1016\/j.bpobgyn.2020.02.008_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"Consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2006","journal-title":"Am J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ypmed.2016.11.029","article-title":"Introduction of molecular HPV testing as the primary technology in cervical cancer screening: acting on evidence to change the current paradigm","volume":"98","author":"Tota","year":"2017","journal-title":"Prev Med"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bpobgyn.2017.08.002","article-title":"Role of HPV DNA testing in modern gynaecological practice","volume":"47","author":"Ronco","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2020.02.008_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/v10120729","article-title":"Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing","volume":"10","author":"Chrysostomou","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib8","first-page":"1","article-title":"Human papillomaviruses","volume":"90","year":"2007","journal-title":"IARC Mu\u00f1oz Eval Carcinog Risks Hum"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib9","series-title":"ICO\/IARC information centre on HPV and cancer (HPV information centre). Human papillomavirus and related diseases in the World","author":"Bruni","year":"2019"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.02.008_bib10","first-page":"330","article-title":"Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance","volume":"125","author":"Huh","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.02.008_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bpobgyn.2011.11.003","article-title":"Human papillomavirus deoxyribonucleic acid testing in developed countries","volume":"26","author":"Bhatla","year":"2012","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.02.008_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Canc"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.02.008_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/eog.11.13","article-title":"Optimizing technology for cervical cancer screening in high-resource settings","volume":"6","author":"Richardson","year":"2011","journal-title":"Expet Rev Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.02.008_bib14","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ygyno.2014.11.076","article-title":"Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test","volume":"136","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib15","series-title":"Summary of commercially available HPV tests in Integrating HPV testing in cervical cancer screening program: a manual for program managers","year":"2016"},{"issue":"12","key":"10.1016\/j.bpobgyn.2020.02.008_bib16","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1128\/JCM.01315-10","article-title":"Feasibility study of a human papillomavirus E6 oncoprotein test for diagnosis of cervical precancer and cancer","volume":"48","author":"Schweizer","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib17","series-title":"World Health Organization model list of essential in\u00a0vitro diagnostics","author":"World Health Organization","year":"2018"},{"issue":"6","key":"10.1016\/j.bpobgyn.2020.02.008_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5306\/wjco.v6.i6.281","article-title":"Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices","volume":"6","author":"Catarino","year":"2015","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib19","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1056\/NEJMoa071430","article-title":"Canadian cervical cancer screening trial study group. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer","volume":"357","author":"Mayrand","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.bpobgyn.2020.02.008_bib20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cmi.2015.04.015","article-title":"Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?","volume":"21","author":"Arbyn","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcv.2018.09.012","article-title":"The Valgent4 protocol: robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium","volume":"108","author":"Bonde","year":"2018","journal-title":"J\u00a0Clin Virol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.02.008_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.02.008_bib23","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ijc.20076","article-title":"POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women","volume":"110","author":"Bulkmans","year":"2004","journal-title":"Int J Canc"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib24","doi-asserted-by":"crossref","first-page":"a1754","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ"},{"issue":"9916","key":"10.1016\/j.bpobgyn.2020.02.008_bib25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomized controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.02.008_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/ijc.30454","article-title":"HPV for cervical cancer screening (HPV FOCAL): complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer","volume":"140","author":"Ogilvie","year":"2017","journal-title":"Int J Canc"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib27","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.bpobgyn.2020.02.008_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.02.008_bib29","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/jnci\/djx225","article-title":"Relative performance of HPV and cytology components of co-testing in cervical screening","volume":"110","author":"Schiffman","year":"2017","journal-title":"JNCI"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.02.008_bib30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ijgo.2015.07.024","article-title":"Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy","volume":"132","author":"Mustafa","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib31","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa0808516","article-title":"HPV screening for cervical cancer in rural India","volume":"360","author":"Sankaranarayanan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.02.008_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/1471-2407-11-239","article-title":"Evaluation of primary HPV-DNA testing in relation to visual inspection methods for cervical cancer screening in rural China: an epidemiologic and cost-effectiveness modelling study","volume":"11","author":"Shi","year":"2011","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.02.008_bib33","first-page":"635","article-title":"Secondary prevention of cervical cancer: ASCO resource-stratified clinical practice guideline","volume":"3","author":"Jeronimo","year":"2016","journal-title":"J\u00a0Global Oncol"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib34","series-title":"IARC handbooks of cancer prevention volume 10: cervix cancer screening","year":"2005"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib35","series-title":"WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention","author":"Who guidelines approved by the guidelines Review Committee","year":"2013"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib36","series-title":"Overview of the renewal","author":"Australian Government Department of Health","year":"2017"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ypmed.2016.11.030","article-title":"Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening","volume":"98","author":"Tota","year":"2017","journal-title":"Prev Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.02.008_bib38","doi-asserted-by":"crossref","first-page":"dju423","DOI":"10.1093\/jnci\/dju423","article-title":"Informed cytology for triaging HPV-positive women: sub study nested in the NTCC randomized controlled trial","volume":"107","author":"Bergeron","year":"2015","journal-title":"JNCI"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.02.008_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2013.12.033","article-title":"HPV testing with cytology triage for cervical cancer screening in routine practice","volume":"210","author":"Louvanto","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"16","key":"10.1016\/j.bpobgyn.2020.02.008_bib40","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.bpobgyn.2020.02.008_bib41","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/ijc.28900","article-title":"The clinical impact of using p16INK4a immunochemistry in cervical histopathology and cytology: an update of recent developments","volume":"136","author":"Bergeron","year":"2015","journal-title":"Int J Canc"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.02.008_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S1470-2045(14)70019-1","article-title":"Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervico-vaginal specimens (PROHTECT-3): a randomized controlled non-inferiority trial","volume":"15","author":"Verhoef","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib43","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J\u00a0Clin Virol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2020.02.008_bib44","first-page":"1","article-title":"Triage of women testing positive with the careHPV test on self-collected vaginal samples for cervical cancer screening in a low-resource setting","volume":"29","author":"Poli","year":"2017","journal-title":"J\u00a0Global Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.02.008_bib45","first-page":"201","article-title":"Screening and management of preinvasive lesions of the cervix: good clinical practice recommendations from the Federation of Obstetrics and Gynaecologic Societies of India (FOGSI)","volume":"46","author":"Bhatla","year":"2019","journal-title":"JOGR"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib46","article-title":"Cancer screening in the European union (2017)","author":"Ponti","year":"2017","journal-title":"Rep Imple Coun Recom Cancer Screen"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.02.008_bib47","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S2468-2667(18)30183-X","article-title":"The projected timeframe until cervical cancer elimination in Australia: a modelling study","volume":"4","author":"Hall","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib48","author":"World Health Organization","year":"2019"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.02.008_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001351","article-title":"Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis","volume":"4","author":"Yeh","year":"2019","journal-title":"BMJ global health"},{"issue":"6","key":"10.1016\/j.bpobgyn.2020.02.008_bib50","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.canep.2009.10.013","article-title":"Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?","volume":"33","author":"Bhatla","year":"2009","journal-title":"Can Epidemiol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.02.008_bib51","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/bjc.2015.474","article-title":"HPV immunization and cervical screening confirmation of changed performance of cytology as a screening test in immunized women: a retrospective population-based cohort study","volume":"114","author":"Palmer","year":"2016","journal-title":"Br J Canc"},{"issue":"11","key":"10.1016\/j.bpobgyn.2020.02.008_bib52","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s11606-016-3772-5","article-title":"Cost-effectiveness of primary HPV testing, cytology and co-testing as cervical cancer screening for women above age 30 years","volume":"31","author":"Jin","year":"2016","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pvr.2015.05.003","article-title":"When and how often to screen for cervical cancer in three low- and middle-income countries: a cost-effectiveness analysis","volume":"1","author":"Campos","year":"2015","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.bpobgyn.2020.02.008_bib54","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ejca.2017.12.018","article-title":"Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: the value of stratifying guidelines","volume":"91","author":"Pedersen","year":"2018","journal-title":"Eur J Canc"},{"issue":"12","key":"10.1016\/j.bpobgyn.2020.02.008_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226335","article-title":"Economic evaluation of HPV DNA test as primary screening method for cervical cancer: a health policy discussion in Greece","volume":"14","author":"Skroumpelos","year":"2019","journal-title":"PloS One"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693420300353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693420300353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:11:32Z","timestamp":1761498692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693420300353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":55,"alternative-id":["S1521693420300353"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2020.02.008","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary HPV screening for cervical cancer","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2020.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}